Hints and tips:
Related Special Reports
Case studies in best practice among general counsel and company legal teams in North America
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...The AU will pay $6.75 a dose for the BioNTech/Pfizer vaccine and $10 for Johnson & Johnson’s, a single-dose product....
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
...The UK’s “magic circle” firms have lost a steady trickle of top lawyers in recent years to deep-pocketed rivals including Latham & Watkins and Kirkland & Ellis....
...Scripps family — Evercore and Kirkland & Ellis Others — UBS and Sullivan & Cromwell served as legal adviser to Advance/Newhouse Welcome to your curated briefing on deals and dealmaking by the Financial...
...Gillespie joined Gibson, Dunn in 2014 from Kirkland & Ellis. Before that, Gillespie was at Allen & Overy....
...The possibility of a Pfizer/AstraZeneca deal still has the politicians talking (the chief executives of both were hauled before the UK parliament this week)....
...beyondbrics India v China: a new race in biopharmaceuticals, beyondbrics...
...Pfizer, the largest US drugmaker by market value, inched down 0.7 per cent to $14.54 as the stock being removed from the “conviction buy” list at Goldman Sachs....
...Last week’s US jobs report has knocked investor confidence, and those predicting a V-shaped recovery are finding it harder to justify their positions....
...This spurred groups such as Pfizer of the US and Roche of Switzerland to strike multi-billion-dollar deals during the first half of this year....
...“We maintain that investors should be wary of confusing an early upturn with a V-shaped recovery,” Mr Shaw said, noting that credit conditions remain strained. ”There are some encouraging, if tentative,...
...Elsewhere in the sector, Shire rose 3 per cent to £10.07 amid renewed talk of a bid from Pfizer....
...Kindler, Chairman and CEO, Pfizer Inc., USA Klaus Kleinfeld, President and CEO, Siemens AG, Germany Mustafa V....
...“This is a technical case but one of very great importance to the business community,” says Kenneth Starr, former Whitewater special prosecutor and a Supreme Court expert at the law firm Kirkland & Ellis...
...He was born in 1954, the year, as he points out, of the famous Brown v Board of Education case which paved the way for US desegregation....
International Edition